NERV - Minerva Neurosciences, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - NERV (1598646)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
27 results - Yahoo - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2020-09-10
NERVVan Heek G JanDirP - Purchase$2.97+7,00020,333+53%+$20,790
2020-05-26
NERVAhlholm Frederick WSVP, Chief Accounting OfficerS - Sale$15.00-8,3396,884-55%-$125,085
D
2019-12-17
NERVRace GeoffEVP, CFO, CBOS - Sale+OE$7.10-5,826205,044-3%-$41,365
D
2019-12-17
NERVLuthringer RemyCEOS - Sale+OE$7.10-2,412975,6440%-$17,125
D
2019-12-17
NERVAhlholm Frederick WSVP, Chief Accounting OfficerS - Sale+OE$7.10-1,55715,223-9%-$11,055
D
2019-12-17
NERVReilly Joseph H.SVP, COOS - Sale+OE$7.10-2,72426,225-9%-$19,340
2019-12-12
NERVRussell Richard E.PresS - Sale$7.42-3,11333,770-8%-$23,098
2019-06-27
NERVDoyle William FDirP - Purchase$5.50+3,50026,111+15%+$19,250
2019-06-26
NERVVan Heek G JanDirP - Purchase$5.37+10,00013,333+300%+$53,700
2019-06-26
NERVHilleman Jeryl LDirP - Purchase$5.25+1,0001,000New+$5,250
2019-06-26
NERVHasler Hans PeterDirP - Purchase$5.60+10,00010,000New+$56,000
2019-06-26
NERVKupfer DavidDirP - Purchase$5.55+10,000247,123+4%+$55,500
2019-06-24
NERVIndex Venture Associates III Ltd10%S - Sale$6.01-197,0003,899,189-5%-$1,184,837
M
2019-06-19
NERVIndex Venture Associates III Ltd10%S - Sale$4.41-110,8184,096,189-3%-$488,911
M
2019-06-17
NERVIndex Venture Associates III Ltd10%S - Sale$4.44-105,9184,207,007-2%-$470,730
M
2019-06-13
NERVIndex Venture Associates III Ltd10%S - Sale$4.51-78,4674,312,925-2%-$353,737
M
2019-06-11
NERVIndex Venture Associates III Ltd10%S - Sale$4.69-60,0514,391,392-1%-$281,343
M
2019-05-17
NERVIndex Venture Associates III Ltd10%S - Sale$6.02-22,9184,451,443-1%-$137,896
M
2019-05-14
NERVIndex Venture Associates III Ltd10%S - Sale$6.66-134,8284,474,361-3%-$898,161
2018-12-20
NERVDoyle William FDirP - Purchase$6.50+2,00022,611+10%+$13,000
D
2018-12-17
NERVRace GeoffEVP, CFO, CBOS - Sale+OE$7.46-5,999198,370-3%-$44,753
D
2018-12-17
NERVAhlholm Frederick WSVP, Chief Accounting OfficerS - Sale+OE$7.46-1,55911,780-12%-$11,630
D
2018-12-17
NERVLuthringer RemyCEOS - Sale+OE$7.46-2,604959,3060%-$19,426
D
2018-12-17
NERVReilly Joseph H.SVP, COOS - Sale+OE$7.46-2,72820,199-12%-$20,351
D
2018-12-12
NERVRussell Richard E.PresS - Sale+OE$7.96-3,11736,883-8%-$24,811
M
2018-12-10
NERVDoyle William FDirP - Purchase$7.97+6,00020,611+41%+$47,800
2018-11-20
NERVDoyle William FDirP - Purchase$8.20+2,00014,611+16%+$16,400
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top